Karyopharm - oncology

Quote




anonymous said:
This is actually pretty funny
Click to expand...

Another strong resemblance:

iu
 




anonymous said:
Companies with ADC programs is very broad. Merck is a great fit with the EC opportunity and their presence in Women's cancer along with the positive results in combo with Ovarian cancer seen in early stage. Incyte is another opportunity as KPTI is positioning themselves well with the PH2 combo trials with several other products in MF along with their excellent Ph1 seli + Rux trial. GSK, GILD, ABBV are also potential good options.
Click to expand...

The compony is a turd. People have had ample opportunities to buy and no interest. What’s different now? No one wants to catch a falling knife either.
 




anonymous said:
The compony is a turd. People have had ample opportunities to buy and no interest. What’s different now? No one wants to catch a falling knife either.
Click to expand...


If the company can stay funded until the Endo readout and subsequent approval it could get back some value. I know it's a huge "IF", however the data does look promising. My guess is potential acquiring companies do not want to take the risk of the data not coming through as we know most of our approvals were no where close to a sure thing. They may be willing to pay more, and by more I mean $10 a share if the Endo data is good and an approval is imminent, versus trying to buy it in the single digits pre readout/approval.
 
































anonymous said:
You’re delusional. No one is interested in this POS.
Click to expand...


Cleary you have no idea how the market works...guessing you are a sales rep who hates working at KPTI, and you think you understand the dynamics of Wall Street because you watch Mad Money. If you can't see the dynamics in play then please, keep shorting the stock and see how that works out for you.
 




anonymous said:
Cleary you have no idea how the market works...guessing you are a sales rep who hates working at KPTI, and you think you understand the dynamics of Wall Street because you watch Mad Money. If you can't see the dynamics in play then please, keep shorting the stock and see how that works out for you.
Click to expand...

derp, derp, derp
 
































Top Bottom
Back
Quote